PT - JOURNAL ARTICLE AU - George A Robinson AU - Junjie Peng AU - Pierre Dönnes AU - Leda Coelewij AU - Anna Radziszewska AU - Chris Wincup AU - Hannah Peckham AU - David A Isenberg AU - Yiannis Ioannou AU - Coziana Ciurtin AU - Ines Pineda-Torra AU - Elizabeth C Jury TI - A machine learning approach for precision diagnosis of juvenile-onset SLE AID - 10.1101/19007765 DP - 2019 Jan 01 TA - medRxiv PG - 19007765 4099 - http://medrxiv.org/content/early/2019/10/05/19007765.short 4100 - http://medrxiv.org/content/early/2019/10/05/19007765.full AB - Juvenile-Onset systemic lupus erythematosus (JSLE) is an autoimmune rheumatic disease characterised by systemic inflammation and organ damage, with disease onset often coinciding with puberty. JSLE is associated with more severe disease manifestations and a higher motility rate compared to adult SLE. Due to the heterogeneous clinical and immunological manifestations of JSLE, delayed diagnosis and poor treatment efficacy are major barriers for improving patient outcome. In order to define a unique immunophenotyping profile distinguishing JSLE patients from age matched healthy controls, immune-based machine learning (ML) approaches were applied. Balanced random forest analysis discriminated JSLE patients from healthy controls with an overall 91% prediction accuracy. The top-ranked immunological features were selected from the optimal ML model and were validated by partial least squares discriminant analysis and logistic regression analysis. Patients could be clustered into four distinct groups based on the top hits from the ML model, providing an opportunity for tailored therapy. Moreover, complex correlations between the JSLE immune profile and clinical features of disease were identified. Further immunological association studies are essential for developing data-driven personalised medicine approaches to aid diagnosis of JSLE for targeted therapy and improved patient outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a PhD studentship from Lupus UK and The Rosetrees Trust (M409) to George Robinson. This work was supported by the Adolescent Centre at UCL UCLH and GOS funded by Arthritis Research UK (20164 and 21953), Great Ormond Street Children’s Charity and the NIHR Biomedical Research Centres at GOSH and UCLH. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The authors declare that no conflict of interests exist.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableAll relevant data is available within the manuscript